IRIS Accounts Production v26.2.0.496 08866896 Board of Directors 1.2.25 31.1.26 31.1.26 0 0 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh088668962025-01-31088668962026-01-31088668962025-02-012026-01-31088668962024-01-31088668962024-02-012025-01-31088668962025-01-3108866896ns15:EnglandWales2025-02-012026-01-3108866896ns14:PoundSterling2025-02-012026-01-3108866896ns10:Director12025-02-012026-01-3108866896ns10:PrivateLimitedCompanyLtd2025-02-012026-01-3108866896ns10:SmallEntities2025-02-012026-01-3108866896ns10:AuditExempt-NoAccountantsReport2025-02-012026-01-3108866896ns10:SmallCompaniesRegimeForDirectorsReport2025-02-012026-01-3108866896ns10:SmallCompaniesRegimeForAccounts2025-02-012026-01-3108866896ns10:FullAccounts2025-02-012026-01-310886689612025-02-012026-01-3108866896ns10:Director22025-02-012026-01-3108866896ns10:Director32025-02-012026-01-3108866896ns10:CompanySecretary12025-02-012026-01-3108866896ns10:RegisteredOffice2025-02-012026-01-3108866896ns5:CurrentFinancialInstruments2026-01-3108866896ns5:CurrentFinancialInstruments2025-01-3108866896ns5:ShareCapital2026-01-3108866896ns5:ShareCapital2025-01-3108866896ns5:RetainedEarningsAccumulatedLosses2026-01-3108866896ns5:RetainedEarningsAccumulatedLosses2025-01-3108866896ns5:IntangibleAssetsOtherThanGoodwill2025-02-012026-01-3108866896ns5:PatentsTrademarksLicencesConcessionsSimilar2025-02-012026-01-3108866896ns5:PatentsTrademarksLicencesConcessionsSimilar2025-01-3108866896ns5:PatentsTrademarksLicencesConcessionsSimilar2026-01-3108866896ns5:PatentsTrademarksLicencesConcessionsSimilar2025-01-3108866896ns5:PlantMachinery2025-01-3108866896ns5:ComputerEquipment2025-01-3108866896ns5:PlantMachinery2025-02-012026-01-3108866896ns5:ComputerEquipment2025-02-012026-01-3108866896ns5:PlantMachinery2026-01-3108866896ns5:ComputerEquipment2026-01-3108866896ns5:PlantMachinery2025-01-3108866896ns5:ComputerEquipment2025-01-3108866896ns5:WithinOneYearns5:CurrentFinancialInstruments2026-01-3108866896ns5:WithinOneYearns5:CurrentFinancialInstruments2025-01-3108866896ns10:Director112025-01-3108866896ns10:Director112024-01-3108866896ns10:Director112025-02-012026-01-3108866896ns10:Director112024-02-012025-01-3108866896ns10:Director112026-01-3108866896ns10:Director112025-01-31
REGISTERED NUMBER: 08866896 (England and Wales)









SALAR SURGICAL LTD

UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 JANUARY 2026






SALAR SURGICAL LTD (REGISTERED NUMBER: 08866896)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2026




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


SALAR SURGICAL LTD

COMPANY INFORMATION
FOR THE YEAR ENDED 31 JANUARY 2026







DIRECTORS: S G Evans
N M Evans
D Foster Fitzsimons





SECRETARY: S G Evans





REGISTERED OFFICE: 7 Sandy Court
Ashleigh Way
Langage Business Park
Plymouth
Devon
PL7 5JX





REGISTERED NUMBER: 08866896 (England and Wales)





ACCOUNTANTS: Wilson Partners Limited
Chartered Accountants
7 Sandy Court
Ashleigh Way
Langage Business Park
Plymouth
Devon
PL7 5JX

SALAR SURGICAL LTD (REGISTERED NUMBER: 08866896)

BALANCE SHEET
31 JANUARY 2026

2026 2025
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 5 13,864 18,906
Tangible assets 6 31,084 41,446
44,948 60,352

CURRENT ASSETS
Debtors 7 7,370 15,919
Cash at bank 18,060 16,904
25,430 32,823
CREDITORS
Amounts falling due within one year 8 33,393 55,925
NET CURRENT LIABILITIES (7,963 ) (23,102 )
TOTAL ASSETS LESS CURRENT LIABILITIES 36,985 37,250

PROVISIONS FOR LIABILITIES 5,900 7,900
NET ASSETS 31,085 29,350

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 30,985 29,250
31,085 29,350

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 January 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 January 2026 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 11 August 2026 and were signed on its behalf by:





S G Evans - Director


SALAR SURGICAL LTD (REGISTERED NUMBER: 08866896)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2026

1. STATUTORY INFORMATION

Salar Surgical Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and the rendering of services.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Patents and licences are being amortised evenly over their estimated useful life of ten years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.

Plant and Machinery - 25% on reducing balance
Computer equipment - 25% on reducing balance

Tangible fixed assets are stated at costs less accumulated depreciation and accumulated impairment losses.

Impairment of Assets

At each reporting date fixed assets are reviewed to determine whether there is any indication that those assets have suffered an impairment loss. If there is an indication of possible impairment, the recoverable amount of any affected asset is estimated and compared with its carrying amount. If the estimated recoverable amount is lower, the carrying amount is reduced to its estimated recoverable amount, and an impairment loss if recognised immediately in profit or loss.

If an impairment loss subsequently reverses, the carrying amount of the asset is increased to the revised estimate of its recoverable amount, but not in excess of the amount that would have been determined had no impairment loss been recognised for the assets in prior years. A reversal of an impairment loss is recognised immediately in profit or loss.

Debtors

Short term debtors are measured at transaction price, less any impairment.

Creditors

Short term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transactions costs, and are measured subsequently at amortised costs using the effective interest method.


SALAR SURGICAL LTD (REGISTERED NUMBER: 08866896)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2026

3. ACCOUNTING POLICIES - continued
Taxation
Current tax is recognised for the amount of income tax payable in respect of the taxable profit for the current or past reporting periods using the tax rates and laws that have been enacted or substantively enacted by the reporting date.

Deferred tax is recognised in respect of all timing differences at the reporting date, except as otherwise indicated.

Deferred tax assets are only recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. If and when all conditions for retaining tax allowances for the cost of a fixed asset have been met, the deferred tax is reversed.

Deferred tax is calculated using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.

The tax expense (income) is presented either in profit or loss, other comprehensive income or equity depending on the transaction that resulted in the tax expense (income).

Provisions for liabilities
Provisions are recognised when the Company has a present (legal or constructive) obligation as a result of a past event; it is probable that an outflow of resources will be required to settle the obligation; and the amount of the obligation can be estimated reliably.

The amount recognised as a provision is the best estimate of the consideration required to settle the present recognised as a provision is the best estimate of the consideration required to settle the present obligation at the end of the reporting period, taking into account the risks and uncertainties surrounding the obligation.

Where the effect of the time value of money is material, the amount expected to be required to settle the obligation is recognised at present value using a pre-tax discount rate. The unwinding of the discount is recognised as a finance costs in profit or loss in the period it arises.

The Company recognises a provision for annual leave accrued by employees for services rendered in the current period, and which employees are entitled to carry forward and use within the next 12 months, measured at the salary costs payable for the period of absence.

4. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2025 - NIL).

5. INTANGIBLE FIXED ASSETS
Patents
and
licences
£   
COST
At 1 February 2025
and 31 January 2026 50,424
AMORTISATION
At 1 February 2025 31,518
Amortisation for year 5,042
At 31 January 2026 36,560
NET BOOK VALUE
At 31 January 2026 13,864
At 31 January 2025 18,906

SALAR SURGICAL LTD (REGISTERED NUMBER: 08866896)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JANUARY 2026

6. TANGIBLE FIXED ASSETS
Plant and Computer
machinery equipment Totals
£    £    £   
COST
At 1 February 2025
and 31 January 2026 63,413 2,881 66,294
DEPRECIATION
At 1 February 2025 22,247 2,601 24,848
Charge for year 10,292 70 10,362
At 31 January 2026 32,539 2,671 35,210
NET BOOK VALUE
At 31 January 2026 30,874 210 31,084
At 31 January 2025 41,166 280 41,446

7. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2026 2025
£    £   
Trade debtors 5,130 15,899
Other debtors 2,240 20
7,370 15,919

8. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2026 2025
£    £   
Trade creditors - 2,785
Taxation and social security 997 1,719
Other creditors 32,396 51,421
33,393 55,925

9. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 January 2026 and 31 January 2025:

2026 2025
£    £   
S G Evans
Balance outstanding at start of year - -
Amounts advanced 2,050 -
Amounts repaid - -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 2,050 -

Loans made to the directors are repayable on demand.

The total overdrawn balance of £2,050 as at 31 January 2026 was cleared on 17 July 2026.